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What to do when a patient’s international medical
care goes south
James W. Jones, MD, PhD, MHA, and Laurence B. McCullough, PhD, Houston, TexThere’s nothing that cleanses your soul like getting the hell
kicked out of you.
Woody Hayes, Former Ohio State Football Coach
A former patient who traveled to a clinic in India
having placement of an Aortic endograft several weeks
ago returned to your clinic with general malaise and has
experienced a low grade fever. The physical examina-
tion is unremarkable but laboratory tests showed sub-
stantial evidence of smoldering infection that cannot be
isolated to an organ system. MRSA grew on cultures
from the groin and blood. The patient traveled abroad
for therapy when you diagnosed the aneurysm because
she was underinsured and remains so. You are consid-
ered one of the foremost authorities on graft infections.
What should you do?
A. Tell her to return from whence she cometh.
B. Alert the news media to the problem of cheap interna-
tional medical care.
C. Advise the patient to sue in international court.
D. Provide care for the patient as you would any other.
E. Advise the patient that once patients leave your care;
they leave permanently. Tell her, “It is not my
problem”.
Globalization is an inevitable modern reality as the
economy stretches world-wide, travel cheapens, and all
earthlings share common problems such as global warm-
ing. Who has not called for computer support or other
technical assistance to discover they are speaking to some-
one halfway around the world? One will search in vain for a
pair of athletic shoes or leisure clothing manufactured in
the United States.
“Medical Tourism” is international economics in ac-
tion as patients seeking cheaper medical care have funded a
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medical care in the United States was technologically un-
surpassed and the wealthy from around the world flocked
here when ill. Many still do; but several decades ago med-
ical centers in Europe began to take more of the interna-
tional healthcare market share, especially from the Middle
East. Currently, with the numbers of foreign medical grad-
uates trained in the United States and the worldwide avail-
ability of technology has made American quality care avail-
able in many other countries. As new therapies are delayed
by thriving American bureaucratism, cutting edge technol-
ogies often become available sooner outside the United
States, including some that shouldn’t, to draw the desper-
ate. Although mainland Europeans can freely cross borders
to other member countries of the European Union, they
rarely do so, even if they live on the border of another
country with shorter waits for therapy.1 The Canadians and
British, on the other hand, do participate in medical tour-
ism because of lengthy delays in certain high-tech proce-
dures. Incredibly, Americans are the largest group of med-
ical tourists with a half million opting to leave what is
assumed to be the best place for medical care in the world.2
Americans have the uninsured problem of almost 50 mil-
lion, lack of coverage for cosmetic and unproven “research”
therapies, and ever increasing co-pays but most travel be-
cause of the priceyness of American medical care. Far
Eastern countries including Malaysia, India, and Singapore
offer procedures at 20% or even 10% of the cost in the US
including air fare and hotel.3,4 Singapore has opened a
second medical school to supply enough future physicians
to treat the growing number of foreign patients.5
This alarming trend is reminiscent, but unlikely to be of
the same magnitude, as the beating that the US auto
industry suffered when car manufacturers considered them-
selves invincible several decades ago. Remember how they
had to radically change their business plan in order to
survive the competition in price and quality of foreign
manufacturers. Much of the American industrial non-com-
petitiveness still is blamed on the cost of medical care.
Whether one manufactures cars or treats patients, volume
eventually translates into quality.
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percentage of the gross national product as other industri-
alized nations without national health statistics being as
good.6 Comparing the costs by procedure between the
United States and other countries can be an eye opener. For
example, with respect to inguinal hernias, “it is less expen-
sive to fly someone roundtrip from Boston to the Shouldice
Hospital for three days and pay the entire bill than to have
the procedure done locally.2
The American Medical Association (AMA) considered
the developing crisis of medical travel outside the United
States serious enough to study the problem this year and
produced a report generally critical of the U.S. healthcare
system. The AMA concluded that, “Currently, competition
in American health care is focused not on patient outcomes
but rather on shifting costs, restricting access, and support-
ing bloated administrative expenses.”2 In an article on
international health care, Wikipedia considers the US med-
ical economic system to suffer from adverse selection to the
extent that it is a market failure.6 This economic aberration
results in the unhealthy being more likely to seek health
insurance (raising costs), the healthy to feel it costs too
much and choosing to be inadequately insured (raising
costs), and insurers expending considerable resources
“weeding out” bad risks (raising costs). The only reason-
able solution to systemic adverse selection appears to be the
Massachusetts compulsory health insurance plan.7 Con-
sider if property taxes were optional. Those starting fami-
lies, needing schools, whose incomes were still growing
would opt in, those who likely would be in a position to pay
the most could opt out, raising the cost alarmingly to those
trapped by the system.
Government regulation, managed care contracts, ex-
pansion of less invasive therapies, and bundling of payment
for operative services have drastically reduced surgeon’s
fees to a relatively small percentage of the cost of medical
care while overall medical care costs continually outstrip the
economy.
The surgical mindset resolutely assigns responsibilities
of medical care specifically to the attending surgeon–not
the assistant, resident, nurses or anesthesiologist – only to
the surgeon of record. This responsibility is independent of
whether other participants in care may have been causal.
The natural implication is that when complications result
from another surgeon’s procedure, the operating surgeon
alone bears full responsibility. An infected graft is a problem
no vascular surgeon wants. Why can’t the surgeon in this
case simply say, “It’s not my problem”? After all, the
surgeon is not causally responsible for this patient’s com-
plication from previous treatment.
The AMA Ethics Principle VI defends the physician’s
right, “except in emergencies, [to] be free to choose whom
to serve, with whom to associate, and the environment in
which to provide medical care.”8 Denial of treatment on
the basis of HIV seropositivity is the AMA’s sole stated
objection to the physician’s ethical entitlement to select the
patients he or she accepts for nonemergent treatment.
There is no evidence in the AMA document that a physi-cian’s personal prejudices may be considered as a basis for
or against patient exclusion.
The fourth edition of the American College of Physi-
cians’ (ACP) Ethics Manual reaffirms the right to refuse
non-emergent care to an individual patient when treatment
is otherwise available.9 However, the manual states that “A
physician may not discriminate against a class or category of
patients.” We assume that medical tourism fails to achieve
category status; the ACP has in mind race, gender, sexual
orientation and other personal characteristics of patients
that, if selected against, result in invidious discrimination.
Declining to treat is valid and ethically necessary when
the therapy sought is unnecessary, futile, or contraindi-
cated,10 when poor patient compliance will severely limit
therapeutic effectiveness,11 or when another available phy-
sician can provide better care.12 Refusing a consultation
request may also be ethically acceptable when there is a
history of personal animus or other conflict of interest
sufficiently negative to harm the physician’s relationship
with a patient.
Rejecting a patient with an urgent need for care that
one is highly qualified to provide because she had sought
affordable medical care elsewhere is ethically questionable.
Such a decision by the surgeon unwarrantably concludes
the causality of a disease determines a physician’s profes-
sional responsibility to the patient. How the disease process
came to be is irrelevant. If it were, most of us would be
guilty of bringing maladies upon ourselves by our lifestyles
and thus deserving our illnesses, would not deserve optimal
therapy. What is relevant is that (1) the patient presented
herself to the surgeon, (2) the surgeon is competent to
diagnose and manage the patient’s problem, and (3) there
exist, in the surgeon’s hospital, the human and technical
resources necessary to provide the requisite clinical man-
agement of her problem.
Options A and E are ethically unacceptable, represent-
ing a fit of pique and not the exercise of professional or
individual conscience. Refusing to treat this patient further-
more violates the professional virtue of self-effacement,
which obligates the surgeon to set aside factors irrelevant to
the care of the patient, especially personal ones. Where the
patient received prior surgery is ethically irrelevant; she is in
need of the expert clinical judgment and skills the surgeon
has to offer. Option A and E also fail the Kantian criteria of
universality of ethical behavior; it would not be proper for
every physician to refuse to provide the best therapy be-
cause of a perceived personal insult, a trivial self-interest, at
best, not valid justification for limiting professional respon-
sibility.
Option B assumes that the patient’s infection was
caused by suboptimal medical care without proof. There is
some evidence that patients having transplant surgery at
international medical centers do well.13 Newspaper articles
are appearing that are quite complementary and one of the
larger healthcare networks in Malaysia treats complications
from their therapies without added charges. Is there an
American hospital willing to take up that gauntlet?
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surgical care bungled in a foreign country where their
malpractice tort systems are practically nonexistent; don’t
expect to sue and get compensated even when compensa-
tion is deserved.3 But even with the high-powered legal
system developed in the United States less than 3% of those
experiencing malpractice sue and less than half of those
suing receive compensation.14 However, the difference in
cost between the two is billions.
Option D is the professional choice. Grumble, if
needed, as you drive home about life’s injustices but taking
care of patients by self-effacing will make one a better
surgeon and a better person.
Also, let’s hope that changes needed in the medical estab-
lishment come about before medicine’s economic soul, like
Detroit’s, improves by “getting the hell kicked out of it.”
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